STOCK TITAN

Mobix Labs (MOBXW) Financials

MOBXW
FY2025 annual
Revenue $9.9M +53.9% YoY
Net Income -$46.1M -130.3% YoY
EPS (Diluted) -$10.15 YoY not available
Free Cash Flow $10.1M -45.0% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 18, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MOBXW SEC filings page.

Mobix Labs (MOBXW) reported $9.9M in revenue for fiscal year 2025, up 53.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MOBXW FY2025

Gross-margin expansion is occurring alongside persistent operating losses, leaving financing central to the business model.

The gap between substantial net losses and positive operating cash flow in both FY2024 and FY2025 indicates that reported earnings are being shaped by noncash items or working-capital movements rather than current-period cash spending alone. Because capital expenditures were minimal, positive free cash flow largely tracks operating cash flow, yet positive financing cash flow in both years shows that cash generation has not removed the need for funding.

Gross margin widened from 39.6% in FY2024 to 50.5% in FY2025 while the operating loss narrowed. The combination is consistent with improved mix, cost absorption, or both, but the available figures do not isolate pricing as the cause.

By FY2025, liabilities exceeded assets and equity had turned negative, while the current ratio was just 0.2x despite long-term debt of $1.1M. That combination points to short-term balance-sheet tightness and obligations broader than conventional debt alone.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 51 / 100
Financial Health Score 51/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Mobix Labs's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
85

Mobix Labs held $3.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $10.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Mobix Labs scores 85/100 among other emerging companies.

Dilution
0

Not available for Mobix Labs, and counted as zero in the overall score.

R&D Intensity
24

Mobix Labs spent $2.4M on research and development in fiscal year 2025, which was 5.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Mobix Labs scores 24/100 among other emerging companies.

Revenue Progress
90

Mobix Labs reported revenue of $9.9M in fiscal year 2025, against $6.4M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Mobix Labs scores 90/100 among other emerging companies.

Burn Trend
93

Mobix Labs's operations generated $10.1M of cash in fiscal year 2025, against $18.4M generated in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Mobix Labs scores 93/100 among other emerging companies.

Balance Sheet
15

Mobix Labs's cash, cash equivalents and investments came to $3.3M at the end of fiscal year 2025, against $37.4M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Mobix Labs scores 15/100 among other emerging companies.

Piotroski F-Score Partial
6/8

Mobix Labs passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Mobix Labs reported a net loss of $46.1M while generating $10.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Mobix Labs reported an operating loss of $37.7M against $2.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$789K
YoY-66.4%
QoQ-18.7%

Mobix Labs generated $789K in revenue in Q3 2026. This represents a decrease of 66.4% from the same quarter a year earlier. Against the prior quarter it is down 18.7%.

EBITDA
-$6.9M
YoY+9.0%
QoQ-22.1%

Mobix Labs's EBITDA was -$6.9M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.0% from the same quarter a year earlier. Against the prior quarter it is down 22.1%.

Net Income
-$16.8M
YoY-103.0%
QoQ-186.9%

Mobix Labs reported -$16.8M in net income in Q3 2026. This represents a decrease of 103.0% from the same quarter a year earlier. Against the prior quarter it is down 186.9%.

EPS (Diluted)
-$1.33
QoQ-125.4%

Mobix Labs earned -$1.33 per diluted share (EPS) in Q3 2026. Against the prior quarter it is down 125.4%.

Cash & Balance Sheet

Cash & Debt
$2.1M
YoY+792.5%
QoQ-16.4%
5Y CAGR+147.2%

Mobix Labs held $2.1M in cash against $2.4M in long-term debt as of Q3 2026.

Shares Outstanding
Diluted avg 13M

Mobix Labs had a weighted average of 13M diluted shares in Q3 2026; the shares outstanding count is not reported for that period.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
12.9%
YoY-44.5pp
QoQ-6.0pp

Mobix Labs's gross margin was 12.9% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 44.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.0 percentage points.

Return on Equity
-268.8%
YoY+1677.5pp
QoQ-202.6pp

Mobix Labs's ROE was -268.8% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 1677.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 202.6 percentage points.

Operating Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$411K
YoY-15.4%
QoQ-4.0%

Mobix Labs invested $411K in research and development in Q3 2026. This represents a decrease of 15.4% from the same quarter a year earlier. Against the prior quarter it is down 4.0%.

Share Buybacks

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

MOBXW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBXW quarterly income statement
MetricQ3'2610-QQ2'2610-KQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$789K-66.4%$970K-61.4%$1.9M-40.8%$1.9M-36.3%$2.4M+14.2%$2.5M+119.3%$3.2M+1011.9%$3.0M+582.2%
Cost of Revenue$687K-31.4%$786K-47.3%$1.3M-12.7%$931K-27.4%$1.0M-24.6%$1.5M+56.6%$1.5M+350.5%$1.3M+196.8%
Gross Profit$102K-92.4%$184K-82.0%$581K-65.6%$951K-43.1%$1.3M+84.5%$1.0M+428.5%$1.7M+3934.1%$1.7M+167100.0%
R&D Expenses$411K-15.4%$428K-40.5%$442K-27.7%$603K-58.4%$486K-64.5%$719K-48.5%$611K-60.9%$1.5M-20.9%
SG&A Expenses$7.0M-14.2%$5.8M-28.1%$9.0M-42.9%$7.5M-25.6%$8.2M-5.8%$8.1M+10.5%$15.7M+0.3%$10.1M+33580.0%
Operating Income-$7.4M+8.9%-$6.1M+22.2%-$8.8M+39.6%-$7.2M+36.1%-$8.1M+13.7%-$7.8M+8.6%-$14.6M+15.3%-$11.2M-4585.5%
EBITDA-$6.9M+9.0%-$5.7M+22.3%-$8.4M+40.3%-$6.7M+37.3%-$7.6M+13.0%-$7.3M+9.3%-$14.0M+17.0%-$10.7M-13020.0%
Interest Expense$868K+58.7%$1.4M+406.9%$1.4M+554.0%$1.3M+269.4%$547K+330.7%$274K+10.5%$211K-75.4%$350K-83.9%
Income Tax$3K+250.0%$3K+160.0%-$24K-1100.0%$16K-95.7%-$2K+99.9%-$5K+68.8%-$2K+99.8%$372K+659.2%
Net Income-$16.8M-103.0%-$5.9M-155.5%-$10.1M+49.0%-$15.7M-36.3%-$8.3M-7.7%-$2.3M-30.7%-$19.8M-2221.8%-$11.5M-196241.0%
EPS (Basic)-$1.33+21.8%-$0.59-3.5%-$1.61+68.8%-$2.99-686.8%-$1.70-580.0%-$0.57-533.3%-$5.16-13000.0%-$0.38-2.7%
EPS (Diluted)-$1.33-$0.59-$1.61-$2.99-$1.70-$0.57-$5.16-$0.39
Diluted Shares (Avg)13M10M6MN/A5M4M4MN/A

MOBXW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBXW quarterly balance sheet
MetricQ3'2610-QQ2'2610-KQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$34.9M+1.1%$34.9M-4.6%$32.7M-12.2%$37.1M-5.1%$34.6M-16.3%$36.5M+23.9%$37.3M-10.1%$39.1M+108.5%
Current Assets$6.0M+64.0%$5.5M+38.2%$2.9M-24.9%$6.7M+27.4%$3.7M-9.7%$4.0M-10.7%$3.8M-75.9%$5.3M+535.1%
Cash & Equivalents$2.1M+792.5%$2.6M+228.2%$268K-33.8%$3.3M+1130.5%$240K+17.1%$781K-73.9%$405K-97.3%$266K+3434.9%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$1.5M+17.3%$1.3M+16.7%$1.2M-5.9%$1.4M-16.8%$1.2M-34.6%$1.1M+206.4%$1.2M+194.3%$1.7M+440.8%
Accounts Receivable$760K-48.7%$724K-56.9%$1.0M-45.7%$1.4M-49.7%$1.5M+0.3%$1.7M+264.2%$1.9M+521.2%$2.8M+5207.5%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$16.1M0.0%$16.1M0.0%$16.1M0.0%$16.1M0.0%$16.1M+5.7%$16.1M+49.3%$16.1M+49.3%$16.1M+208.0%
Total Liabilities$26.7M-21.7%$26.0M-28.1%$28.1M-30.4%$37.4M+11.6%$34.1M+4.2%$36.2M+42.8%$40.3M+8.7%$33.6M+54.0%
Current Liabilities$22.1M-17.0%$24.0M-23.7%$25.2M-11.2%$27.8M+6.4%$26.7M+4.7%$31.5M+74.7%$28.4M+32.6%$26.1M+27.8%
Non-Current Liabilities$4.6M-38.6%$2.0M-57.9%$2.8M-76.3%$9.7M+29.7%$7.4M+2.7%$4.7M-35.7%$11.9M-24.1%$7.5M+445.5%
Long-Term Debt$2.4M+73.1%$1.0M+83.0%$1.9M+119.8%$1.1M-14.3%$1.4M-57.1%$552K-82.5%$873K-82.4%$1.3M-80.5%
Total Equity$6.2M+1370.1%$8.8M+2486.3%$4.7M+253.6%-$336K-106.1%$425K-95.0%$342K-91.8%-$3.0M-169.6%$5.5M+203.5%
Retained Earnings-$183.4M-36.0%-$166.6M-31.6%-$160.7M-29.3%-$150.6M-44.2%-$134.9M-45.1%-$126.6M-48.5%-$124.3M-50.1%-$104.5M-24.7%

MOBXW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBXW quarterly cash flow statement
MetricQ3'2610-QQ2'2610-KQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$5.7M-39.6%-$4.3M-625.6%-$4.8M-412.4%$15.7M-52.6%-$4.1M-32.7%-$586K+92.8%-$930K+74.1%$33.2M+2225.3%
Depreciation & Amortization$437K-6.4%$424K-20.0%$455K-23.4%$467K-13.7%$467K-23.2%$530K+2.7%$594K+69.7%$541K+68.0%
Stock-Based Compensation$2.4M-66.9%$2.5M-26.8%$5.1M-47.6%N/A$7.1M+96.1%$3.4M+132.6%$9.8M-22.8%N/A
Capital ExpendituresN/AN/AN/A$10K-99.0%$0-100.0%N/AN/A-$1.0M
Free Cash FlowN/AN/AN/A$15.7M-51.1%-$4.1M-30.7%N/AN/A$32.1M
Investing Cash FlowN/AN/AN/A-$10K$27K-35.7%N/AN/A$0+100.0%
Financing Cash Flow$5.3M+50.5%$6.5M+569.4%$1.8M+64.6%$7.6M+105.2%$3.5M+1317.7%$978K+136.6%$1.1M-94.2%$3.7M+136.5%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MOBXW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOBXW quarterly financial ratios
MetricQ3'2610-QQ2'2610-KQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin12.9%-44.5pp19.0%-21.6pp31.0%-22.2pp50.5%-6.1pp57.4%+21.9pp40.6%+23.8pp53.2%+68.7pp56.6%+56.4pp
Operating Margin-932.1%-627.9%-471.1%-380.7%-343.4%-311.8%-461.7%-379.7%
Net Margin-2128.6%-603.4%-540.0%-835.8%-352.0%-91.2%-626.0%-390.6%
Return on Equity-268.8%+1677.5pp-66.2%+603.7pp-217.0%N/A-1946.3%-1856.4pp-669.9%-627.7ppN/A-208.6%
Return on Assets-48.1%-24.1pp-16.8%-10.5pp-30.9%+22.3pp-42.4%-12.9pp-23.9%-5.3pp-6.3%-0.3pp-53.2%-55.5pp-29.5%-29.5pp
Current Ratio0.27+0.1x0.23+0.1x0.110.0x0.240.0x0.140.0x0.13-0.1x0.13-0.6x0.20+0.2x
Debt-to-Equity0.38-2.9x0.11-1.5x0.41N/A3.25+2.9x1.61+0.9xN/A0.23
Asset Turnover0.020.0x0.030.0x0.060.0x0.050.0x0.070.0x0.070.0x0.09+0.1x0.08+0.1x
FCF MarginN/AN/AN/A834.4%-173.8%N/AN/A1087.9%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$336K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.24), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Mobix Labs's annual revenue?

Mobix Labs (MOBXW) reported $9.9M in total revenue for fiscal year 2025. This represents a 53.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Mobix Labs's revenue growing?

Mobix Labs (MOBXW) revenue grew by 53.9% year-over-year, from $6.4M to $9.9M in fiscal year 2025.

Is Mobix Labs profitable?

No, Mobix Labs (MOBXW) reported a net income of -$46.1M in fiscal year 2025.

Mobix Labs (MOBXW) reported diluted earnings per share of -$10.15 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Mobix Labs (MOBXW) had EBITDA of -$35.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Mobix Labs (MOBXW) had $3.3M in cash and equivalents against $1.1M in long-term debt.

Mobix Labs (MOBXW) had a gross margin of 50.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Mobix Labs (MOBXW) generated $10.1M in free cash flow during fiscal year 2025. This represents a -45.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Mobix Labs (MOBXW) generated $10.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Mobix Labs (MOBXW) had $37.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Mobix Labs (MOBXW) invested $26K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Mobix Labs (MOBXW) invested $2.4M in research and development during fiscal year 2025.

Mobix Labs (MOBXW) had a current ratio of 0.24 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Mobix Labs (MOBXW) had a return on assets of -124.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Mobix Labs (MOBXW) has negative shareholder equity of -$336K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Mobix Labs (MOBXW) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Mobix Labs (MOBXW) reported a net loss of $46.1M while generating $10.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Mobix Labs (MOBXW) reported an operating loss of $37.7M against $2.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Mobix Labs (MOBXW) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top